For further information, please contact:
Jorge Almenara, Ph.D.
General Manager
Bernhardt Laboratories
P: 804.551.1598
Brad Bernhardt
Director of Product Development
Anatomic Pathology Division, Sonic Healthcare USA
P: 904.813.3088
Reference: Kris MG, Johnson BE, Berry LD, et al. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA. 2014;311(19):1998-2006.